The Preferred Biotech Resource in Asia-Pacific
Vol 19, No 07, July 2015
Biotech in China
Kh-biotech cover


Eye on China


Conferences ListingConferences

Pharma Sales
Click here to download ISSUE PDF
Vol 18, No 07, July 2014 - Translational Medicine



•  Less frequent dosing in hemophilia B patients shows improved pharmacokinetic profile
•  Novogen identifies highly active drug candidates against prostate cancer

•  Gold nanoprobes used to unlock genetic profiles
•  Clinical checks to detect relapses for patients with peripheral T-cell lymphoma just as effective as imaging
•  QT Vascular initiates chocolate cases in Singapore

•  Trial set for world's first leprosy vaccine
•  Nickel-eating Philippine plant may have wide usesx.html">

•  New study to investigate dabigatran etexilate for prevention of recurrent stroke in high-risk patients
•  Researchers use DNA to build tool that may literally shine light on cancer

•  Scientists slow brain tumor growth in mice
•  Researchers pinpoint new role for enzyme in DNA repair, kidney cancer
•  Progress on multiple sclerosis treatment with embryonic stem cells
•  Researchers develop vaccine candidate using genetically engineered malaria parasite

•  ScinoPharm and Lee's Pharmaceutical jointly develop drug products for the Chinese market
•  WuXi PharmaTech begins construction of new R&D and cGMP manufacturing campus in Changzhou
•  NeoStem signs Licensing Agreement with Cellular Biomedicine Group and plans to begin Phase 2 hepatocellular carcinoma trial in China
•  Abiogen Pharma signed agreement with Lee's Pharma to market Neridronic Acid in mainland China, Taiwan, Hong Kong and Macau
•  InSightec launches its first centers in China
•  Shuwen Biotech and DiagnoCure sign exclusive agreement for commercializing colorectal cancer staging test in China
•  The Jackson Laboratory and Frasergen to begin creation of cancer genomics facility in Hubei Province, China
•  RuiYi and iHuman Institute form collaboration to identify novel antibodies targeting GPCRs
•  Enigma Diagnostics and China's ICDC collaborate to develop MDX infectious disease assays for use at point-of-care
•  Drug to inhibit liver cancer discovered

•  Translating Research at SingHealth: Cancer
•  Translating Research at SingHealth: Cardiometabollic Diseases
•  Translating Research at SingHealth: Eye Diseases
•  Translating Research at SingHealth: Health Services Research
•  Translating Research at SingHealth: Infectious Diseases
•  Translating Research at SingHealth: Neurosciences (Stroke)

•  Treating Asthma Differently

•  Sanford-Burnham and Daiichi Sankyo form alliance to study novel drug targets in cardiovascular metabolic diseases
•  Sigma-Aldrich® to launch Austrianova's Cell-in-a-Box® Kit for research use
•  ASLAN Pharmaceuticals signs agreement with CSL to develop novel therapy for asthma
•  Self-assembling peptides for bone regeneration and drug delivery
•  Verisante Technology, Inc. receives the 2014 North American Technology Innovation Leadership of the Year Award from Frost & Sullivan
•  Agilent Technologies partners Women in Science, Engineering and Technology in Korea
•  Mundipharma and Genewel sign agreement across key global markets for licensing and promotion of Medifoam®
•  Janssen collaborates with ViiV Healthcare to develop two-drug single tablet regimen for the maintenance treatment of people living with HIV
•  AbbVie opens expanded manufacturing facility in Sligo, Ireland
•  AMRI to Acquire Oso Biopharmaceuticals Manufacturing
•  Merck to collaborate with Sysmex Inostics on a blood-based RAS biomarker test
•  Igenbio establishes direct presence in Japan
•  Mesoblast accelerates plans for commercial manufacturing operations in Singapore
•  Celerion and Korean Drug Development Fund form collaboration to strengthen early phase clinical research in South Korea
•  Dr. Carolyn Mountford, University of Newcastle, Australia receives Agilent Technologies Thought Leader Award
•  PHARM Connect — The business summit covering a full industry
•  New topics for the Next Generation Sequencing & Single Cell Genomics Asia Congress confirmed
•  Registration opened for Oxford Global's 6th Annual Next Generation Sequencing Congress